PMH52 PILOT SURVEY OF ADVERSE EVENT MANAGEMENT ASSOCIATED WITH ANTIPSYCHOTIC USE: THE NEGLECTED DIMENSION IN RESOURCE USE IMPLICATIONS (A UK PERSPECTIVE)
Meier G, Malcolm B AstraZeneca, Luton, Bedfordshire, UK OBJECTIVES: A pilot survey was conducted to determine which NHS services and resources may possibly be impacted in the management of adverse events (ADEs) related to antipsychotic use. METHODS: Ten UK mental health specialists were interviewed. The six-question survey advised participants to assume that patients' psychotic symptoms were controlled or that it was too early in therapy to determine efficacy. The ADEs considered were limited to those identified by NICE as most troublesome, i.e. sedation, extrapyramidal symptoms (EPS), weight gain and sexual dysfunction. RESULTS: The most common routine tests performed were: full blood count, glucose, cholesterol and weight. Action was prompted for sedation and sexual dysfunction only if the patient raised a concern. For weight gain and EPS, clinician and patient concerns were given equal consideration. Actions taken in order of preference were: sedation-decrease dose, change timing, switch treatment; EPS-decrease dose, add anticholinergic, switch treatment; weight gain-switch treatment, decrease dose; sexual dysfunction-decrease dose, switch treatment, add sildenafil. Referrals were mentioned in all responses but were most commonly associated with weight gain and sexual dysfunction. Most common tests requested as a result of an ADE assessment were: glucose, weight, cholesterol and prolactin. Switching treatment was the most common action in response to positive tests results for any ADE. CONCLUSIONS: This pilot survey highlights that ADEs could play a substantial role in treatment costs given the potential use of resources linked to their observation, diagnosis and management. As such, in order to comprehensively calculate the cost-effectiveness of any antipsychotic treatment, acquisition costs as well as costs associated with potential adverse event management should be considered. To confirm the findings of this survey, further in-depth research is warranted. Hospital del Sureste, Arganda del Rey, Spain OBJECTIVES: To fully describe patients' characteristics, management patterns, predictive recurrence factors and economic impact of health care attention of bipolar patients population in Spain. The description of the sample of an ongoing cohort study is being presented. METHODS: Prospective observational cohort study with a follow-up of 12 months including consecutive outpatients diagnosed of Bipolar Disorder I or II (DSM-IV-TR), stabilized for at least 2 months, who had at least a mood disorder episode (depression, mania, hypomania or mixed) in the last year. RESULTS: A total of 571 patients were included, 60.1% women. Mean age was 47.4 years (SD 13.1). Only 37.5% were active workers, up to 5.4% were having temporal disability leave and 16.2% were permanent disabled for working. Regarding study disease, 75% were bipolar I and mean time since diagnosis was 12.3 years (SD 10.5), although time since first mood episode compatible with bipolar diagnose was 16.3 years (SD 11.2). Mean mood episode number since disease onset was 10.6 (SD 9.3). Up to 74.1% of patients had been hospitalised during the disease evolution, mean times were 3.6 (SD 3.3). 21.3% of patients have had a suicide attempt. Regarding the baseline evaluation, 29.9% of patients were not free of mood symptoms even being stabilized for at least two months, presenting more than two mania symptoms (10.6%) and more than 2 depression symptoms (18.2%). CONCLUSIONS: Even in the stabilization phase of the disease there is an important symptoms load. Although depressive symptoms are more frequent than manic symptoms, both subsyndromal symptoms are present in euthimic bipolar patients. Bipolar disorder is a relevant chronic
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